安潔科技(002635.SZ):重慶安潔擬出資2億元在重慶設立兩全資子公司
格隆匯6月29日丨安潔科技(002635.SZ)公佈,公司於2021年6月28日召開第四屆董事會第二十七次會議,審議通過了《關於設立全資孫公司的議案》,公司子公司重慶安潔擬使用自籌資金1億元設立其全資子公司重慶萬盛安潔電子有限公司(暫定名)和擬使用自籌資金1億元設立其全資子公司重慶安潔金屬表面處理有限公司(暫定名)。
公司表示,該次設立全資孫公司是基於適應公司整體戰略發展和滿足業務拓展的需要、優化產業佈局所做的決策,有利於擴大公司西部地區業務,進一步滿足公司生產經營和建設發展的需要,滿足客户產能配套需求,提高公司的業務競爭能力,拓展公司發展空間,促進公司持續、健康發展,維護股東長遠利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.